Top U.S. Stories

Markets

Global markets were rattled by a sharp AI-and-chip stock selloff centered in Asia. Japan’s Nikkei 225 plunged 2,134.31 points, or 3.16%, to close at 65,326.42, falling below the 66,000 mark for the first time in about two weeks, as SoftBank Group, Advantest, and other AI/chip names were hit hard following Tuesday’s U.S. semiconductor selloff. South Korea’s KOSPI dropped 5.8% on similar chip-sector exposure. The dollar bought 159.09 yen as of August 19, with Japan’s long-term bond yields hitting their highest level since 1996 amid growing expectations that the Bank of Japan will raise rates as soon as September. WTI crude traded in the low-to-mid $85 range, briefly touching $86, rising for a third straight session on stalled U.S.-Iran talks.

Stocks in Focus

  • SoftBank Group / Advantest (Japan): Led the Nikkei’s decline as AI/chip names sold off in sympathy with U.S. peers.
  • Kioxia / Fujikura (Japan): Fell 12.6% and 9.73% respectively amid the broad semiconductor rout.
  • Moderna (U.S.): Jumped 177% on strong melanoma vaccine trial data developed with Merck.

This is not a recommendation to buy or sell any security.

Compass Insight

Today’s throughline is interest rates. Rising expectations for a Bank of Japan hike pushed Japanese long-term yields to their highest since 1996, and that same rate anxiety spilled into a sharp selloff in AI and chip stocks across Asia. U.S. markets, by contrast, found relief after the Treasury moved to increase debt buybacks, easing bond-yield pressure and letting the Dow, S&P, and Nasdaq post modest gains. For households, a firmer yen and higher yields cut two ways: import costs may ease, but rising oil prices and eventual mortgage-rate resets could offset that relief over time. In the short run, expect AI-linked stocks to stay sensitive to every rate-related headline; over the medium term, the pace of the BOJ’s tightening — and its knock-on effect on borrowing costs — is the thing worth watching most closely.


Sources:

Auto-generated and AI-written. Not investment advice.